De-risk therapeutic antibody drug development using humanized fcrn mice

Who speaks for your community health center’s interests in Washington, D.C.? Who advocates for policy in technology and healthcare sectors so you can uphold your mission to serve the underserved?Join us to hear how athenahealth actively engages with policymakers in Congress to help make healthcare work as it should. We’ll discuss our areas of focus for 2018/2019, particularly those areas of uncertainty that will affect how you serve your community. Bring your questions.

Healthcare is moving to the consumer, offering unprecedented power to patients and new market entrants. And, as data becomes dominant in driving innovation and integration forward, how is the industry responding? How is AI creating new opportunities and challenges? And, in what ways are industry leaders redefining the ways in which we think about “healthcare”? Breaking down the expected 2019 trends – featuring insights from HIMSS19 and CES – Validic CEO Drew Schiller and Kaiser Permanente CHIO John Mattison detail the the year ahead. Tune in for your roadmap to 2019 digital health innovation.

This CLE webinar will provide healthcare counsel with guidance on overcoming the regulatory challenges involved when providing telemedicine services internationally. The panel will discuss the obstacles, such as FCPA compliance, when developing and operating an international telehealth program. The panel will examine the regulatory issues that face healthcare providers, hospitals and health systems when providing telehealth services outside the U.S.

Digital report only. This is the second edition of the Investing in Healthcare and Real Estate Report, LaingBuisson’s annual report into the role of real estate and healthcare REITS in UK healthcare market.